Kenneth L. Londoner's Insider Trades & SAST Disclosures
Kenneth L. Londoner's most recent trade in Biosig Technologies Inc was a trade of 219,700 Common Stock done . Disclosure was reported to the exchange on Nov. 30, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kenneth L. Londoner.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biosig Technologies Inc | L. Londoner Kenneth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 219,700 | 2,726,720 (10%) | 0% | 0 | Common Stock | |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.24 per share. | 13 Jun 2023 | 10,000 | 2,501,420 (9%) | 0% | 1.2 | 12,400 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 13 Jun 2023 | 3,000 | 2,504,420 (9%) | 0% | 1.3 | 3,780 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 13 Jun 2023 | 2,000 | 2,506,420 (9%) | 0% | 1.2 | 2,440 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 13 Jun 2023 | 600 | 2,507,020 (9%) | 0% | 1.2 | 738 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 12 Jun 2023 | 2,000 | 2,487,420 (9%) | 0% | 1.1 | 2,200 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 12 Jun 2023 | 2,000 | 2,491,420 (9%) | 0% | 1.2 | 2,400 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.22 per share. | 12 Jun 2023 | 2,000 | 2,489,420 (9%) | 0% | 1.2 | 2,440 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.37 per share. | 31 May 2023 | 3,000 | 2,484,820 (9%) | 0% | 1.4 | 4,110 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 31 May 2023 | 2,000 | 2,475,820 (9%) | 0% | 1.6 | 3,100 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.58 per share. | 31 May 2023 | 1,000 | 2,478,820 (9%) | 0% | 1.6 | 1,580 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.57 per share. | 31 May 2023 | 1,000 | 2,477,820 (9%) | 0% | 1.6 | 1,570 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 31 May 2023 | 1,000 | 2,476,820 (9%) | 0% | 1.6 | 1,560 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 31 May 2023 | 1,000 | 2,473,820 (9%) | 0% | 1.6 | 1,560 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 31 May 2023 | 1,000 | 2,481,820 (9%) | 0% | 1.3 | 1,320 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 31 May 2023 | 1,000 | 2,480,820 (9%) | 0% | 1.6 | 1,600 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.59 per share. | 31 May 2023 | 1,000 | 2,479,820 (9%) | 0% | 1.6 | 1,590 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.44 per share. | 31 May 2023 | 400 | 2,485,420 (9%) | 0% | 1.4 | 576 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.43 per share. | 31 May 2023 | 200 | 2,485,020 (9%) | 0% | 1.4 | 286 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 576,000 | 2,472,820 (9%) | 2% | 0 | Common Stock | |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 08 Sep 2022 | 11,760 | 1,863,120 (7%) | 0% | 0.8 | 9,761 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 08 Sep 2022 | 7,006 | 1,851,360 (7%) | 0% | 0.8 | 5,885 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 08 Sep 2022 | 5,400 | 1,888,120 (7%) | 0% | 0.8 | 4,536 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 08 Sep 2022 | 5,200 | 1,879,220 (7%) | 0% | 0.8 | 4,212 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 08 Sep 2022 | 5,000 | 1,872,120 (7%) | 0% | 0.8 | 3,875 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 08 Sep 2022 | 3,000 | 1,882,220 (7%) | 0% | 0.8 | 2,400 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 08 Sep 2022 | 3,000 | 1,896,820 (7%) | 0% | 0.8 | 2,460 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 08 Sep 2022 | 2,500 | 1,890,620 (7%) | 0% | 0.8 | 1,975 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.94 per share. | 08 Sep 2022 | 2,000 | 1,892,820 (7%) | 0% | 0.9 | 1,880 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 08 Sep 2022 | 2,000 | 1,866,120 (7%) | 0% | 0.8 | 1,692 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 08 Sep 2022 | 1,900 | 1,874,020 (7%) | 0% | 0.8 | 1,550 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 08 Sep 2022 | 1,000 | 1,893,820 (7%) | 0% | 0.8 | 830 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 08 Sep 2022 | 1,000 | 1,867,120 (7%) | 0% | 0.9 | 870 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 08 Sep 2022 | 500 | 1,882,720 (7%) | 0% | 0.9 | 425 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 08 Sep 2022 | 500 | 1,864,120 (7%) | 0% | 0.9 | 440 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 08 Sep 2022 | 500 | 1,863,620 (7%) | 0% | 0.9 | 425 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 08 Sep 2022 | 200 | 1,890,820 (7%) | 0% | 0.8 | 156 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 07 Sep 2022 | 3,250 | 1,843,354 (7%) | 0% | 0.8 | 2,665 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 07 Sep 2022 | 2,000 | 1,840,104 (7%) | 0% | 0.8 | 1,680 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 07 Sep 2022 | 1,000 | 1,844,354 (7%) | 0% | 0.8 | 830 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 07 Sep 2022 | 500 | 1,838,104 (7%) | 0% | 1.0 | 483 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 07 Sep 2022 | 500 | 1,837,604 (7%) | 0% | 1.1 | 550 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 02 Sep 2022 | 3,000 | 1,827,804 (7%) | 0% | 1.1 | 3,270 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 02 Sep 2022 | 2,500 | 1,830,304 (7%) | 0% | 1.1 | 2,675 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 02 Sep 2022 | 2,400 | 1,835,104 (7%) | 0% | 1.0 | 2,448 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 02 Sep 2022 | 1,000 | 1,837,806 (7%) | 0% | 1.0 | 1,010 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 02 Sep 2022 | 1,000 | 1,836,104 (7%) | 0% | 1 | 1,000 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 02 Sep 2022 | 1,000 | 1,832,204 (7%) | 0% | 1.0 | 1,030 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 02 Sep 2022 | 500 | 1,832,704 (7%) | 0% | 1.0 | 513 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 02 Sep 2022 | 500 | 1,831,204 (7%) | 0% | 1.1 | 540 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 02 Sep 2022 | 400 | 1,830,704 (7%) | 0% | 1.1 | 425 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 01 Sep 2022 | 17,240 | 1,824,804 (7%) | 0% | 1.1 | 18,704 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 29 Aug 2022 | 6,100 | 1,797,564 (6%) | 0% | 1.1 | 6,710 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 29 Aug 2022 | 4,000 | 1,802,564 (6%) | 0% | 1.1 | 4,280 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 29 Aug 2022 | 2,000 | 1,805,564 (6%) | 0% | 1.1 | 2,180 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 29 Aug 2022 | 2,000 | 1,807,564 (6%) | 0% | 1.1 | 2,120 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 29 Aug 2022 | 1,000 | 1,790,714 (6%) | 0% | 1.1 | 1,080 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 29 Aug 2022 | 1,000 | 1,803,564 (6%) | 0% | 1.2 | 1,160 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 29 Aug 2022 | 1,000 | 1,798,564 (6%) | 0% | 1.0 | 1,010 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 29 Aug 2022 | 250 | 1,791,464 (6%) | 0% | 1.1 | 274 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 29 Aug 2022 | 250 | 1,791,214 (6%) | 0% | 1.1 | 272 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 29 Aug 2022 | 250 | 1,790,964 (6%) | 0% | 1.1 | 272 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.19 per share. | 25 Aug 2022 | 7,400 | 1,780,388 (6%) | 0% | 1.2 | 8,806 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 25 Aug 2022 | 3,000 | 1,784,438 (6%) | 0% | 1.2 | 3,450 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 25 Aug 2022 | 1,000 | 1,785,614 (6%) | 0% | 1.2 | 1,180 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 25 Aug 2022 | 1,000 | 1,786,614 (6%) | 0% | 1.2 | 1,170 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.12 per share. | 25 Aug 2022 | 1,000 | 1,787,614 (6%) | 0% | 1.1 | 1,120 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.08 per share. | 25 Aug 2022 | 1,000 | 1,788,714 (6%) | 0% | 1.1 | 1,080 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.07 per share. | 25 Aug 2022 | 1,000 | 1,789,714 (6%) | 0% | 1.1 | 1,070 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.18 per share. | 25 Aug 2022 | 450 | 1,780,838 (6%) | 0% | 1.2 | 531 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 25 Aug 2022 | 200 | 1,781,038 (6%) | 0% | 1.2 | 234 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 25 Aug 2022 | 200 | 1,781,238 (6%) | 0% | 1.2 | 232 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 25 Aug 2022 | 200 | 1,781,438 (6%) | 0% | 1.2 | 230 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 25 Aug 2022 | 176 | 1,784,614 (6%) | 0% | 1.1 | 202 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.09 per share. | 25 Aug 2022 | 100 | 1,787,714 (6%) | 0% | 1.1 | 109 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 23 Aug 2022 | 5,000 | 1,765,988 (6%) | 0% | 1.1 | 5,250 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 23 Aug 2022 | 2,000 | 1,771,988 (6%) | 0% | 1.1 | 2,200 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 23 Aug 2022 | 2,000 | 1,769,988 (6%) | 0% | 1.2 | 2,300 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 23 Aug 2022 | 1,000 | 1,766,988 (6%) | 0% | 1.0 | 1,040 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 23 Aug 2022 | 1,000 | 1,772,988 (6%) | 0% | 1.1 | 1,100 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 23 Aug 2022 | 1,000 | 1,767,988 (6%) | 0% | 1.2 | 1,150 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 19 Aug 2022 | 4,000 | 1,760,988 (6%) | 0% | 1 | 4,000 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 19 Aug 2022 | 3,000 | 1,756,988 (6%) | 0% | 1 | 3,000 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 19 Aug 2022 | 3,000 | 1,753,988 (6%) | 0% | 1.0 | 3,030 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.99 per share. | 17 Aug 2022 | 6,000 | 1,750,988 (6%) | 0% | 1.0 | 5,940 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 17 Aug 2022 | 4,000 | 1,743,088 (6%) | 0% | 1.0 | 3,880 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.98 per share. | 17 Aug 2022 | 1,300 | 1,744,988 (6%) | 0% | 1.0 | 1,274 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 17 Aug 2022 | 600 | 1,743,688 (6%) | 0% | 0.9 | 516 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 17 Aug 2022 | 500 | 1,738,388 (6%) | 0% | 0.9 | 440 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 17 Aug 2022 | 400 | 1,739,088 (6%) | 0% | 0.8 | 336 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 17 Aug 2022 | 300 | 1,738,688 (6%) | 0% | 0.9 | 273 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 16 Aug 2022 | 5,000 | 1,733,788 (6%) | 0% | 0.9 | 4,500 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 16 Aug 2022 | 5,000 | 1,723,788 (6%) | 0% | 0.9 | 4,400 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 16 Aug 2022 | 4,100 | 1,737,888 (6%) | 0% | 1.0 | 3,936 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 16 Aug 2022 | 4,000 | 1,728,788 (6%) | 0% | 0.9 | 3,470 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.92 per share. | 16 Aug 2022 | 3,000 | 1,715,788 (6%) | 0% | 0.9 | 2,766 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 16 Aug 2022 | 3,000 | 1,718,788 (6%) | 0% | 0.9 | 2,730 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 16 Aug 2022 | 1,000 | 1,724,788 (6%) | 0% | 0.8 | 800 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 25 May 2022 | 9,300 | 1,712,788 (6%) | 0% | 1.2 | 10,695 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.10 per share. | 24 May 2022 | 8,744 | 1,703,488 (6%) | 0% | 1.1 | 9,601 | Common Stock |
| Biosig Technologies Inc | Kenneth L. Londoner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 20 May 2022 | 11,850 | 1,694,744 (6%) | 0% | 1.1 | 13,539 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges